HSF1 | Heat shock transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPB1 | Heat shock 27kDa protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
HSPD1 | Heat shock 60kDa protein 1 (chaperonin) | Cancer-related genes Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
HSPH1 | Heat shock 105kDa/110kDa protein 1 | Cancer-related genes
| | | | | Expressed in all |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
KRT18 | Keratin 18 | Cancer-related genes Disease related genes
| | | | | Mixed |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
LMNA | Lamin A/C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MCM2 | Minichromosome maintenance complex component 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM5 | Minichromosome maintenance complex component 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM7 | Minichromosome maintenance complex component 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MGMT | O-6-methylguanine-DNA methyltransferase | Cancer-related genes Enzymes
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MVP | Major vault protein | Cancer-related genes Cytoskeleton related proteins
| | | | | Expressed in all |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Transcription factors
| | | | | Mixed |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
PARP1 | Poly (ADP-ribose) polymerase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PCNA | Proliferating cell nuclear antigen | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
PML | Promyelocytic leukemia | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PSMD4 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | Cancer-related genes
| | | | | Expressed in all |
RPA2 | Replication protein A2, 32kDa | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
RPS6KA1 | Ribosomal protein S6 kinase, 90kDa, polypeptide 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
S100A6 | S100 calcium binding protein A6 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
SDC1 | Syndecan 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SEPT2 | Septin 2 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SOD1 | Superoxide dismutase 1, soluble | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SOX9 | SRY (sex determining region Y)-box 9 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
STMN1 | Stathmin 1 | Cancer-related genes
| | | | | Expressed in all |
TFDP1 | Transcription factor Dp-1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
TSG101 | Tumor susceptibility 101 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |